Child & Adolescent Psychopharmacology 2023

March 17, 2023 to March 19, 2023

Join us at Disney's Aulani Resort & Spa
for our annual Child & Adolescent Psychopharmacology Conference

Complex challenges and evolving guidelines are changing the way you care for young psychiatric patients. These areas include new diagnostic criteria, patient-centered care models, new trends in substance abuse, research advances on genetics, and much more. It is more important than ever to find education that not only covers all these topics, but is also innovative, engaging, and empowers you to reach improved outcomes.

That's why it's critical to attend this hands-on, comprehensive conference. It provides psychiatrists, pediatricians, primary care and family practice physicians, nursing professionals, psychologists, social workers, and other mental health professionals with insights to optimize your assessment, treatment, and management of child and adolescent patients with psychiatric conditions.

  • Meet and engage face-to-face with renowned clinician-researchers who share the latest advances in their fields
  • Find guidance for complex signs and symptoms such as emotional outbursts, mood swings, and strange eating habits that can be indicative of psychiatric disorders yet can also be part of normal child development
  • Translate the latest research into optimal assessment and treatment strategies for anxiety, substance abuse, depression, eating disorders, OCD, psychosis, and much more


MDs/Doctoral-Level Professionals
Super Early Bird Registration (on or before January 15, 2023): $795.00
Early Bird Registration (January 16-February 15, 2023): $895.00
Regular Registration (after February 15, 2023): $995.00

Other Professionals or Trainees
Super Early Bird Registration (on or before January 15, 2023): $695.00
Early Bird Registration (January 16-February 15, 2023): $795.00
Regular Registration (after February 15, 2023): $895.00

Cancellation Policy

A refund minus a $100.00 administrative fee will be issued for refund requests received by February 25, 2023.  No refunds will be issued for refund requests made after February 25, 2023. Payments made may not be applied to future conferences or other educational activities.  There are no exceptions to these policies.

***The deeply discounted Super Early Bird Registration rate is NON-REFUNDABLE and NON-TRANSFERABLE and will not be refunded under any circumstances.


The conference syllabus is a printed book with all slide presentations and space to take notes adjacent to each slide.

Syllabus Book: $50

We provide all attendees  with completely free access to all slide presentations in digital PDF format prior to the conference. This is an environmentally friendly alternative and helps keep costs lower for all attendees. The e-syllabus will be available for 30 days after the conference. 

Massachusetts General Hospital Psychiatry Update & Board Preparation, 4th Edition

Board certification and recertification exams are critical career moments. That is why you should rely on the Massachusetts General Hospital Psychiatry Update & Board Preparation, Fourth Edition. It puts our 80+ years of clinical experience at your fingertips to help you prepare for your exam.

Purchase a print copy of our Board Preparation book here!


Target Audience

  • Psychiatrists
  • Primary care and family practice physicians
  • Pediatricians
  • Psychologists
  • Nursing professionals
  • Social workers
  • Residents
  • Other mental health, primary care and pediatric clinicians

Learning Objectives

  • Recognize the presentation, diagnosis, and current treatment options available for attention deficit and hyperactivity in childhood and adolescence.
  • Identify the presentation, diagnosis, and current treatment options available for behavioral problems and pervasive developmental disorders.
  • Discuss the presentation, diagnosis, and current treatment options available for depression, psychosis, manic depression, and anxiety.
  • Compare and contrast basic neuropharmacology, neuropsychologic testing data, psychopharmacologic properties of compounds, and the implications of psychiatric genetics for guiding day-to-day pediatric psychopharmacology treatment.
  • Recognize the risk management issues associated with adolescent substance use disorder and smoking, ethical and safe use of psychotropics, suicide risk and prevention, cardiovascular side effects and medical liability of stimulants, and liability prevention in psychopharmacology.
  • Review the comorbidity of ADHD with post-traumatic stress disorder and traumatic brain injury.
  • Explore emotional dysregulation, executive function and learning disorders in the context of ADHD.
  • Describe the relationship between antidepressants and suicide risk.
  • Discuss the available naturopathic treatments for emotional dysregulation in youth, including pros, cons, and available evidence.
  • Examine the evidence base for the Pediatric Autoimmune Neurological Disorder Associated with Streptococcus symptoms and its relation to OCD.
  • Describe the presentation, diagnosis, and current treatment options available for childhood onset schizophrenia.
  • Compare and contrast psychotherapeutic treatment approaches for children including DBT, CBT, and others.
  • Explore how animal models provide insight into child and adolescent psychiatric conditions, using ADHD as a model system.
  • Compare and contrast emotional dysregulation from mania, including presentation, course, and treatment.
  • Examine the relationship between learning disorders and ADHD.
  • Describe adult ADHD and discuss the controversies surrounding its diagnosis and treatment.
  • Examine the legal issues involved in treating individuals with ADHD and related disorders.
  • Describe the problems associated with treatment non-adherence and provide strategies to improve adherence in the clinical setting.
Course summary
Course opens: 
Course expires: 
Event starts: 
03/17/2023 - 8:00am EDT
Event ends: 
03/19/2023 - 5:00pm EDT
Aulani, A Disney Resort & Spa
Ko Olina, HI
United States
+1 (866) 443-4763

Join us at Disney's Aulani Resort & Spa
for our annual Child & Adolescent Psychopharmacology Conference

Walt Disney Imagineers worked hand in hand with local artisans and cultural experts to create Aulani, A Disney Resort & Spa. Inspired by the natural wonders and rich traditions of Hawai‘i, Aulani Resort is the ultimate family getaway—celebrating the beauty, history and welcoming spirit of the island.


We are offering our valued attendees a special discounted room rate.

Reserve your room now!

CE information is pending.


Please login or register to take this course.


Joseph Biederman, MD
Thomas J. Spencer, MD
Timothy E. Wilens, MD
Jane Pimental, MPH
David H. Rubin, MD, reviewer
Susan E. Sprich, PhD psychologist reviwer

Policy on Faculty and Provider Disclosure

It is the policy of McLean Hospital that faculty and providers disclose real or apparent conflicts of interest relating to the topics of this educational activity. McLean Hospital has established policies in place that identify and resolve all conflicts of interest prior to this educational activity.

Resolution of Conflict of Interest (COI)

McLean Hospital has implemented a process to resolve COI for each CME activity. In order to help ensure content objectivity, independence, fair balance and ensure that the content is aligned with the interest of the public, McLean Hospital has resolved the conflict by External Content Review.